Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Truist Securities Downgrades MEI Pharma to Hold

Truist Securities Downgrades MEI Pharma to Hold

Truist Securities analyst Robyn Karnauskas downgrades MEI Pharma (NASDAQ:MEIP) from Buy to Hold.

December 6, 2022

1 minute read

Truist Securities analyst Robyn Karnauskas downgrades MEI Pharma (NASDAQ:MEIP) from Buy to Hold.

What 6 Analyst Ratings Have To Say About KBR

July 17, 8:00 AM

Within the last quarter, KBR (NYSE:KBR) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

June 15, 10:09 AM

Gibson Energy, Inc. (OTC: GBNXF) plans to

May 10, 2:13 PM

Flux Power Holdings Inc (NASDAQ:FLUX) reported worse-than-expected third-quarter financial results on Thursday. Flux Power posted GAAP loss of…

April 14, 8:52 AM

For the Years Ended